Molecular action of class I antiarrhythmic drugs and clinical implications

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This report briefly reviews the advance in our knowledge of cellular electrophysiological effects of membrane stabilizer antiarrhythmic drugs (sodium channel blockers) including some new ones. The class I drugs block cardiac sodium channels and differ in the kinetics of the interaction with sodium channels and in the actions on the repolarization phase. The class I drugs can be subdivided into subclasses (I a,b,c). This review focuses on the interaction of these drugs with sodium channels and the molecular models of their action. The interaction of class I drugs with the sodium channel receptor is influenced by the state of the myocardium (pH, ischaemia) and by other drugs as well. The clinical implications of different actions of sodium channel blockers, alone and in combination, and their proarrhythmic effects are summarized.

Original languageEnglish
Pages (from-to)131-142
Number of pages12
JournalPharmacological Research
Volume24
Issue number2
DOIs
Publication statusPublished - 1991

Fingerprint

Sodium Channels
Anti-Arrhythmia Agents
Sodium Channel Blockers
Pharmaceutical Preparations
Molecular Models
Drug Interactions
Myocardium
Ischemia
Membranes

Keywords

  • antiarrhythmic drugs
  • cellular electrophysiology
  • proarrhythmic effects of antiarrhythmic drugs
  • sodium channel blockers

ASJC Scopus subject areas

  • Pharmacology

Cite this

Molecular action of class I antiarrhythmic drugs and clinical implications. / Kecskeméti, V.

In: Pharmacological Research, Vol. 24, No. 2, 1991, p. 131-142.

Research output: Contribution to journalArticle

@article{fe7c1081e15449c382c6660dc4ae3e2f,
title = "Molecular action of class I antiarrhythmic drugs and clinical implications",
abstract = "This report briefly reviews the advance in our knowledge of cellular electrophysiological effects of membrane stabilizer antiarrhythmic drugs (sodium channel blockers) including some new ones. The class I drugs block cardiac sodium channels and differ in the kinetics of the interaction with sodium channels and in the actions on the repolarization phase. The class I drugs can be subdivided into subclasses (I a,b,c). This review focuses on the interaction of these drugs with sodium channels and the molecular models of their action. The interaction of class I drugs with the sodium channel receptor is influenced by the state of the myocardium (pH, ischaemia) and by other drugs as well. The clinical implications of different actions of sodium channel blockers, alone and in combination, and their proarrhythmic effects are summarized.",
keywords = "antiarrhythmic drugs, cellular electrophysiology, proarrhythmic effects of antiarrhythmic drugs, sodium channel blockers",
author = "V. Kecskem{\'e}ti",
year = "1991",
doi = "10.1016/1043-6618(91)90028-V",
language = "English",
volume = "24",
pages = "131--142",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Molecular action of class I antiarrhythmic drugs and clinical implications

AU - Kecskeméti, V.

PY - 1991

Y1 - 1991

N2 - This report briefly reviews the advance in our knowledge of cellular electrophysiological effects of membrane stabilizer antiarrhythmic drugs (sodium channel blockers) including some new ones. The class I drugs block cardiac sodium channels and differ in the kinetics of the interaction with sodium channels and in the actions on the repolarization phase. The class I drugs can be subdivided into subclasses (I a,b,c). This review focuses on the interaction of these drugs with sodium channels and the molecular models of their action. The interaction of class I drugs with the sodium channel receptor is influenced by the state of the myocardium (pH, ischaemia) and by other drugs as well. The clinical implications of different actions of sodium channel blockers, alone and in combination, and their proarrhythmic effects are summarized.

AB - This report briefly reviews the advance in our knowledge of cellular electrophysiological effects of membrane stabilizer antiarrhythmic drugs (sodium channel blockers) including some new ones. The class I drugs block cardiac sodium channels and differ in the kinetics of the interaction with sodium channels and in the actions on the repolarization phase. The class I drugs can be subdivided into subclasses (I a,b,c). This review focuses on the interaction of these drugs with sodium channels and the molecular models of their action. The interaction of class I drugs with the sodium channel receptor is influenced by the state of the myocardium (pH, ischaemia) and by other drugs as well. The clinical implications of different actions of sodium channel blockers, alone and in combination, and their proarrhythmic effects are summarized.

KW - antiarrhythmic drugs

KW - cellular electrophysiology

KW - proarrhythmic effects of antiarrhythmic drugs

KW - sodium channel blockers

UR - http://www.scopus.com/inward/record.url?scp=0025822969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025822969&partnerID=8YFLogxK

U2 - 10.1016/1043-6618(91)90028-V

DO - 10.1016/1043-6618(91)90028-V

M3 - Article

C2 - 1749744

AN - SCOPUS:0025822969

VL - 24

SP - 131

EP - 142

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 2

ER -